Uscom Ltd

AU:UCM Australia Medical Devices
Market Cap
$1.93 Million
AU$3.12 Million AUD
Market Cap Rank
#37872 Global
#1441 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$0.48
Categories
Companies in Australia Medical Devices
About

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more

Uscom Ltd (UCM) - Net Assets

Latest net assets as of June 2025: AU$-38.22K AUD

Based on the latest financial reports, Uscom Ltd (UCM) has net assets worth AU$-38.22K AUD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$3.25 Million) and total liabilities (AU$3.29 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$-38.22K
% of Total Assets -1.18%
Annual Growth Rate N/A
5-Year Change -101.24%
10-Year Change -100.77%
Growth Volatility 48.02

Uscom Ltd - Net Assets Trend (2003–2025)

This chart illustrates how Uscom Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Uscom Ltd (2003–2025)

The table below shows the annual net assets of Uscom Ltd from 2003 to 2025.

Year Net Assets Change
2025-06-30 AU$-38.22K -101.25%
2024-06-30 AU$3.06 Million +0.56%
2023-06-30 AU$3.04 Million -48.71%
2022-06-30 AU$5.94 Million +92.85%
2021-06-30 AU$3.08 Million -10.07%
2020-06-30 AU$3.42 Million -1.88%
2019-06-30 AU$3.49 Million -28.01%
2018-06-30 AU$4.84 Million +28.24%
2017-06-30 AU$3.78 Million -23.49%
2016-06-30 AU$4.94 Million +115.76%
2015-06-30 AU$2.29 Million -31.05%
2014-06-30 AU$3.32 Million +40.97%
2013-06-30 AU$2.35 Million +60.17%
2012-06-30 AU$1.47 Million -53.12%
2011-06-30 AU$3.14 Million +27.98%
2010-06-30 AU$2.45 Million -19.83%
2009-06-30 AU$3.06 Million -10.26%
2008-06-30 AU$3.41 Million -38.04%
2007-06-30 AU$5.50 Million -35.41%
2006-06-30 AU$8.51 Million -27.56%
2005-06-30 AU$11.75 Million -17.81%
2004-06-30 AU$14.29 Million -7.45%
2003-06-30 AU$15.44 Million --

Equity Component Analysis

This analysis shows how different components contribute to Uscom Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 4372456400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$40.44 Million %
Other Comprehensive Income AU$4.41 Million %
Total Equity AU$-38.22K 100.00%

Uscom Ltd Competitors by Market Cap

The table below lists competitors of Uscom Ltd ranked by their market capitalization.

Company Market Cap
Embention Sistemas Inteligentes S.A.
PA:MLUAV
 		$411.98K
SODEXO - Dusseldorf Stock Exchang
DU:SJ7
 		$412.03K
Search Minerals Inc
PINK:SHCMF
 		$412.04K
KURITA WATER IND
MU:KWI
 		$412.12K
Primarindo Asia Infrastructure Tbk PT
JK:BIMA
 		$411.80K
BRUKER
BE:BKD
 		$411.66K
Curtiss Motorcycles Company Inc
PINK:CMOT
 		$411.06K
SODEXO
BE:SJ7
 		$410.68K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Uscom Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 3,061,050 to -38,224, a change of -3,099,274 (-101.2%).
  • Net loss of 3,302,759 reduced equity.
  • Other comprehensive income increased equity by 191,463.
  • Other factors increased equity by 12,022.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-3.30 Million -8640.54%
Other Comprehensive Income AU$191.46K +500.9%
Other Changes AU$12.02K +31.45%
Total Change AU$- -101.25%

Book Value vs Market Value Analysis

This analysis compares Uscom Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-06-30 AU$0.41 AU$0.01 x
2004-06-30 AU$0.41 AU$0.01 x
2005-06-30 AU$0.30 AU$0.01 x
2006-06-30 AU$0.22 AU$0.01 x
2007-06-30 AU$0.14 AU$0.01 x
2008-06-30 AU$0.09 AU$0.01 x
2009-06-30 AU$0.08 AU$0.01 x
2010-06-30 AU$0.06 AU$0.01 x
2011-06-30 AU$0.07 AU$0.01 x
2012-06-30 AU$0.03 AU$0.01 x
2013-06-30 AU$0.04 AU$0.01 x
2014-06-30 AU$0.04 AU$0.01 x
2015-06-30 AU$0.03 AU$0.01 x
2016-06-30 AU$0.05 AU$0.01 x
2017-06-30 AU$0.03 AU$0.01 x
2018-06-30 AU$0.04 AU$0.01 x
2019-06-30 AU$0.03 AU$0.01 x
2020-06-30 AU$0.02 AU$0.01 x
2021-06-30 AU$0.02 AU$0.01 x
2022-06-30 AU$0.03 AU$0.01 x
2023-06-30 AU$0.02 AU$0.01 x
2024-06-30 AU$0.02 AU$0.01 x
2025-06-30 AU$0.00 AU$0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Uscom Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -128.07%
  • • Asset Turnover: 0.79x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-49.48%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 -8.76% -325.63% 0.03x 1.02x AU$-2.68 Million
2005 -21.67% -530.28% 0.04x 1.03x AU$-3.72 Million
2006 -39.65% -301.37% 0.12x 1.08x AU$-4.23 Million
2007 -58.16% -366.92% 0.15x 1.08x AU$-3.75 Million
2008 -63.85% -206.76% 0.28x 1.10x AU$-2.52 Million
2009 -35.99% -67.46% 0.46x 1.15x AU$-1.41 Million
2010 -71.74% -210.02% 0.30x 1.16x AU$-2.00 Million
2011 -85.66% -320.52% 0.24x 1.12x AU$-3.00 Million
2012 -124.11% -229.75% 0.43x 1.24x AU$-1.97 Million
2013 -58.25% -237.01% 0.21x 1.20x AU$-1.61 Million
2014 -45.81% -143.92% 0.28x 1.14x AU$-1.85 Million
2015 -53.12% -59.61% 0.69x 1.28x AU$-1.44 Million
2016 -38.78% -65.21% 0.51x 1.16x AU$-2.41 Million
2017 -47.67% -51.47% 0.78x 1.19x AU$-2.18 Million
2018 -40.48% -68.52% 0.53x 1.11x AU$-2.45 Million
2019 -39.83% -38.15% 0.88x 1.19x AU$-1.74 Million
2020 -38.90% -38.26% 0.59x 1.73x AU$-1.67 Million
2021 -30.03% -23.96% 0.72x 1.73x AU$-1.23 Million
2022 -33.23% -78.59% 0.31x 1.35x AU$-2.57 Million
2023 -85.11% -97.25% 0.51x 1.70x AU$-2.90 Million
2024 -67.78% -55.67% 0.73x 1.68x AU$-2.38 Million
2025 0.00% -128.07% 0.79x 0.00x AU$-3.30 Million

Industry Comparison

This section compares Uscom Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $14,750,885
  • Average return on equity (ROE) among peers: -315.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Uscom Ltd (UCM) AU$-38.22K -8.76% N/A $411.93K
4DMEDICAL Ltd (4DX) $926.64K -85.93% 0.18x $1.08 Billion
Adherium Ltd (ADR) $34.53 Million -3.63% 0.08x $2.37 Million
Aroa Biosurgery Ltd (ARX) $-22.65 Million 0.00% 0.00x $91.94 Million
Atomo Diagnostics Ltd (AT1) $34.48 Million -26.73% 0.05x $8.72 Million
Control Bionics Ltd (CBL) $6.09 Million -15.97% 0.04x $4.72 Million
Cardiex Ltd (CDX) $3.03 Million -101.61% 0.73x $4.25 Million
Compumedics Ltd (CMP) $9.21 Million -30.70% 1.16x $12.44 Million
Cochlear Ltd (COH) $75.42 Million 53.19% 1.13x $6.95 Billion
Cleo Diagnostics Ltd (COV) $5.83 Million -68.54% 0.19x $23.23 Million
Conneqt Health Limited (CQT) $633.50K -2871.98% 13.72x $4.66 Million